LMAT Q3 2025 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena

LMATLeMaitre Vascular, Inc.

$3B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$61M+11.4% YoY

Gross Profit

$46M75.3% margin

Operating Income

$20M33.3% margin

Net Income

$17M28.4% margin

EPS (Diluted)

$0.75

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$598M

Total Liabilities

$219M

Stockholders' Equity

$379M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$61M	$55M	+11.4%
Gross Profit	$46M	$37M	+23.6%
Operating Income	$20M	$13M	+54.5%
Net Income	$17M	$11M	+55.8%

Revenue Segments

Operating Segments

$61M100%

Geographic Segments

UNITED STATES

$35M60%

Other Countries

$15M26%

GERMANY

$4M8%

CANADA

$4M7%